Liveramp Holdings, Inc. quarterly report, Q3 FY2016

Business context and reporting period

Filing identity differs from the request metadata: the supplied Form 10-Q is for Acxiom Corporation and subsidiaries, not LiveRamp Holdings, Inc. Acxiom owned LiveRamp as a subsidiary. The filing covers the quarter and nine months ended December 31, 2015—Acxiom’s fiscal third quarter and first nine months of fiscal 2016. The financial statements are unaudited.

Acxiom described itself as an enterprise data, analytics and software-as-a-service company. Its reported continuing segments were Marketing Services, Audience Solutions and Connectivity. The company sold its IT Infrastructure Management business (ITO) on July 31, 2015 and presents it as discontinued operations.

Financial performance and position

Amounts below are in U.S. dollars; financial statement amounts are converted from thousands to millions.

MetricQuarter ended Dec. 31, 2015Nine months ended Dec. 31, 2015
Revenue$221.2 million$625.4 million
Gross profit / margin$95.5 million / 43.2%$260.7 million / 41.7%
Operating loss$0.4 million$5.3 million
Continuing-operations net loss$0.4 million$7.0 million
Net earnings (loss), including discontinued operations$(1.4) million$8.3 million
Continuing-operations diluted EPS$(0.01)$(0.09)
  • Quarter revenue increased 6.2% year over year; excluding unfavorable foreign exchange, management reported growth of 7.2%. Nine-month revenue increased 4.4%, or 5.6% excluding unfavorable foreign exchange.
  • Quarter segment revenue: Marketing Services $115.7 million (+1.2%); Audience Solutions $77.0 million (+1.5%); Connectivity $28.4 million (+58.7%). Nine-month revenue was flat in Marketing Services, down 4.1% in Audience Solutions and up 99.6% in Connectivity.
  • Quarter gross margin rose from 39.6% to 43.2%, which management attributed primarily to Connectivity growth and cost efficiencies. Nine-month margin rose from 38.9% to 41.7%.
  • Operating cash flow was $70.4 million for the nine months, versus $31.8 million a year earlier. Continuing-operations investing activities used $50.7 million, including $33.8 million of capital expenditures and $10.4 million of capitalized software costs; financing activities used $108.4 million.
  • Cash and cash equivalents were $186.4 million at December 31, 2015. Working capital was $180.5 million, down from $253.2 million at March 31, primarily due to the ITO disposition. Trade receivables were $140.8 million; days sales outstanding rose to 59 from 56.
  • Total debt and capital leases were $200.9 million, including $192.5 million of term-loan borrowings; there were no revolving-credit borrowings. The term-loan weighted-average interest rate was 2.6%. Acxiom reported compliance with its debt covenants.

Material changes versus prior comparable periods

  • Quarter revenue rose 6.2%, while operating loss narrowed to $0.4 million from $2.3 million. Continuing-operations results shifted to a $0.4 million loss from $0.3 million of earnings.
  • Quarter operating expenses increased 13.1% to $95.8 million, including higher sales and marketing and general and administrative costs. Nine-month operating loss narrowed to $5.3 million from $21.8 million.
  • Connectivity’s rapid growth, largely reflecting LiveRamp and new customer additions, contrasted with weaker international Marketing Services and Audience Solutions results. Nine-month Audience Solutions revenue fell 4.1%, including declines in international markets.
  • Nine-month net earnings of $8.3 million included $15.2 million of earnings from discontinued operations; continuing operations remained loss-making. The prior-year quarter included $3.8 million of discontinued-operations earnings.
  • Cash increased by $45.4 million from March 31. The ITO sale generated $131.0 million of consideration after closing adjustments and transaction costs; $55.0 million was used to repay debt. Debt and capital leases declined from $280.1 million at March 31.

Outlook, management commentary and risks

  • No specific revenue, earnings or margin guidance is provided. Management stated that it believed liquidity and capital resources would be sufficient to operate the business, while noting that financing or capital-market transactions could be considered depending on needs and market conditions.
  • The ITO sale may yield up to $50 million in contingent payments through 2020, subject to performance metrics; receipt is uncertain. The company also retained a right to participate in certain distributions above a defined amount.
  • Credit amendments tied to the ITO sale modified certain covenants through March 31, 2016, prohibited dividends during that period and limited share repurchases to no more than $100 million, depending on leverage. The filing says prior covenant and distribution terms were to resume after that date.
  • Acxiom repurchased $37.5 million of stock during the nine months. The program authorized up to $300 million through December 31, 2016; approximately $60 million of capacity remained at quarter-end.
  • Unusual items included $7.3 million of nine-month restructuring charges and adjustments, a $0.7 million impairment charge associated with Brazil, and a $9.3 million gain on the ITO sale included in discontinued operations. An interim APAC goodwill test found reduced estimated fair value but no impairment; further deterioration could prompt additional testing and charges.
  • Principal disclosed risks include foreign-exchange exposure, customer and contract losses, data availability and privacy/regulatory changes, data-security or service interruptions, acquisition integration, and the possibility of further goodwill impairment. The company reported no pending legal matter considered material to its financial statements and said disclosure controls were effective.

Important facts for investors to verify

  • Confirm the intended issuer: this source is Acxiom Corporation’s 10-Q, not a LiveRamp Holdings filing.
  • Assess continuing-operations performance separately from discontinued-operation results and the ITO sale gain.
  • Evaluate whether Connectivity growth and gross-margin improvement can persist, given comparatively weak performance in some other segments and international markets.
  • Review debt maturities, covenant and repurchase restrictions, and the status of the post-March 2016 credit terms.
  • Do not treat the possible ITO contingent consideration as assured cash proceeds; verify whether performance conditions are met.